Akebia Announces Pricing Of Public Offering Of Common Stock Post author:Sam Post published:June 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA's Shorten Review Time is a Bad Sign for Puma Biotech's Controversial Cancer Drug April 18, 2017 Arcturus CEO Ousted, Effective Immediately February 1, 2018 German Biotech InflaRx Snags $100M in IPO November 8, 2017